SP0119 The evolving role of mepolizumab in egpa
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.7727
Abstract: There is overwhelming evidence that eosinophiles play a key role in the pathogenesis of EGPA. Il-5 is the central cytokine for eosinophil maturation, eosinophil release from the bone marrow and eosinophil survival. Mepolizumab is an… read more here.
Keywords: evolving role; mepolizumab; remission; mepolizumab egpa ... See more keywords